摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(3-(8,8-dimethyl-5-p-tolyl-7,8-dihydronaphthalen-2-yl)-4,5-dihydroisoxazol-5-yl)]benzoic acid | 1178898-46-8

中文名称
——
中文别名
——
英文名称
4-[(3-(8,8-dimethyl-5-p-tolyl-7,8-dihydronaphthalen-2-yl)-4,5-dihydroisoxazol-5-yl)]benzoic acid
英文别名
4-[3-[8,8-dimethyl-5-(4-methylphenyl)-7H-naphthalen-2-yl]-4,5-dihydro-1,2-oxazol-5-yl]benzoic acid
4-[(3-(8,8-dimethyl-5-p-tolyl-7,8-dihydronaphthalen-2-yl)-4,5-dihydroisoxazol-5-yl)]benzoic acid化学式
CAS
1178898-46-8
化学式
C29H27NO3
mdl
——
分子量
437.538
InChiKey
HMEUJWHCAZDZME-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.3
  • 重原子数:
    33
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    58.9
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    4-[(1E)-3-(7,8-dihydro-8,8-dimethyl-5-p-tolylnaphthalen-2-yl)-3-oxoprop-1-en-1-yl]-benzoic acid盐酸羟胺sodium acetate 作用下, 以 甲醇 为溶剂, 反应 16.0h, 以93%的产率得到4-[(3-(8,8-dimethyl-5-p-tolyl-7,8-dihydronaphthalen-2-yl)-4,5-dihydroisoxazol-5-yl)]benzoic acid
    参考文献:
    名称:
    Retinoid receptor subtype-selective modulators through synthetic modifications of RARγ agonists
    摘要:
    A series of retinoids designed to interfere with the repositioning of H12 have been synthesized to identify novel RAR gamma antagonists based on the structure of known RAR gamma agonists. The transcriptional activities of the novel ligands were revealed by cell-based reporting assays, using engineered cells containg RAR subtype-selective fusions of the RAR ligand-binding domains with the yeast GAL4 activator DNA-binding domain and the cognate luciferase reporter gene. Whereas none of the ligands exhibited features of a selective RAR gamma antagonist, some of them are endowed with interesting activities. In particular 24a acts as a pan-RAR agonist that induces at high concentration a higher transactivation potential on RAR alpha than TTNPB and synergizes at low concentration with TTNPB-bound RAR alpha but not RAR beta or RAR gamma. Similarly, 24c synergizes with TTNPB-bound RAR gamma and exhibits RAR alpha,beta antagonist activity. Compounds 24b and 25b are strong RAR alpha,beta-selective antagonists without agonist or antagonist activities for RAR gamma. Compounds 24b and 24c display weak RXR antagonist activity. In addition several pan-antagonists and partial agonist/antagonists have been defined. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.05.035
点击查看最新优质反应信息

文献信息

  • Retinoid receptor subtype-selective modulators through synthetic modifications of RARγ agonists
    作者:Susana Álvarez、Rosana Álvarez、Harshal Khanwalkar、Pierre Germain、Géraldine Lemaire、Fátima Rodríguez-Barrios、Hinrich Gronemeyer、Ángel R. de Lera
    DOI:10.1016/j.bmc.2009.05.035
    日期:2009.7
    A series of retinoids designed to interfere with the repositioning of H12 have been synthesized to identify novel RAR gamma antagonists based on the structure of known RAR gamma agonists. The transcriptional activities of the novel ligands were revealed by cell-based reporting assays, using engineered cells containg RAR subtype-selective fusions of the RAR ligand-binding domains with the yeast GAL4 activator DNA-binding domain and the cognate luciferase reporter gene. Whereas none of the ligands exhibited features of a selective RAR gamma antagonist, some of them are endowed with interesting activities. In particular 24a acts as a pan-RAR agonist that induces at high concentration a higher transactivation potential on RAR alpha than TTNPB and synergizes at low concentration with TTNPB-bound RAR alpha but not RAR beta or RAR gamma. Similarly, 24c synergizes with TTNPB-bound RAR gamma and exhibits RAR alpha,beta antagonist activity. Compounds 24b and 25b are strong RAR alpha,beta-selective antagonists without agonist or antagonist activities for RAR gamma. Compounds 24b and 24c display weak RXR antagonist activity. In addition several pan-antagonists and partial agonist/antagonists have been defined. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多